Scholarly Index
Lucia Seminario‐Vidal
Eli Lilly (United States); 2,354 total citations; 123 total publications; best world rank #111
Eli Lilly (United States)
2,354Total citations
123Total publications
26H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cutaneous lymphoproliferative disorders research | Lifetime | 940 | US 369 | 92.46 |
| Drug-Induced Adverse Reactions | Lifetime | 861 | US 261 | 91.44 |
| Cutaneous lymphoproliferative disorders research | 2021-2025 | 111 | US 42 | 94.63 |
| Nail Diseases and Treatments | 2021-2025 | 369 | US 84 | 84.04 |
| T-cell and Retrovirus Studies | 2021-2025 | 469 | US 103 | 72.49 |